PR Newswire
JERUSALEM, Israel, June 19, 2017
JERUSALEM, Israel, June 19, 2017 /PRNewswire/ --
IDenta Corp. (OTC PINK: IDTA), a world leader in the development of field kits, has developed a patent for the
identification of Fentanyl. Fentanyl is a very dangerous drug that causes the death of people every day around the globe. There
is an extensive demand for the new kit by some of the most important and leading police forces which has
an affect worldwide, with countries looking for an urgent solution like IDenta's unique patent to save lives.
About IDenta Corp .
Since 2002, IDenta Corporation and its subsidiary IDenta Ltd are recognized as a worldwide leader in the development of
proprietary on-site Drug, Precursor of Drug and Explosive detection kits. IDenta develops, manufactures and distributes
revolutionary products for both the professional and civil markets which consistently pass the highest qualifications and testing
procedures of law enforcement and security agencies around the world.
Disclaimer
Certain statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements"
that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the
forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors
which may cause the actual results, performance or achievements of the company to be materially different from any future
results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements
are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any
of these statements in the future.
Contact
Amichai Glattstein, COO
T: +972-2587-2220
E: amichai@identa-corp.com
SOURCE Identa Corp
